DOCUMENT RESOURCES FOR EVERYONE
Documents tagged
Education 10-10-04_02 Vance Ablott: Triangle Coalition

Triangle Coalition Collaborating for Better STEM Education Vance Ablott Triangle Coalition [email protected] Our Mission Triangle Coalitionâs Mission is to…

Technology Climate Change Liability

1. Climate Change Liability The Evolving Legal Framework October 14, 2008 Munich Re Climate Change and Liability Workshop Princeton, New Jersey 2. What We Know 3. Intergovernmental…

Education US Federal Education and Language Policy Update - July 2014

1. U.S. Federal Education and Language Policy Update John Segota, CAE Associate Executive Director for Public Policy & Professional Relations 2. Overview • 113th Congress…

Business Temporal Innovativeness

1. Temporal Innovativeness Dr Stephen Dann AMPR, QUT 2. Temporal innovativeness attitudinal measure“the degree to which the adopter desires to be the earliest member of…

Education US Federal Education & Language Policy Update

1. U.S. Federal Education and Language Policy Update John Segota, CAE Associate Executive Director for Public Policy & Professional Relations 2014 TESOL International…

Education TESOL Education Policy Update: The View From DC

1. TESOL Education Policy Outlook: the View from DCJohn Segota, CAE Associate Executive Director for Public Policy & Professional Relations 2013 GATESOL Conference 2.…

Healthcare Quality Manufacturing in Healthcare ASQ 2015

Discovery Discussion Manufacturing in the Healthcare Industry: Quality Challenges and Tools Gerard J. Pearce Executive Vice President SQA Services, Inc. 22nd Annual Conference…

Documents New Antimicrobial

Approval and Withdrawal of New Antibiotics and Other Antiinfectives in the U.S., 1980-2009 Kevin Outterson, John H. Powers, Enrique Seoane-Vazquez, Rosa Rodriguez-Monguio,…

Health & Medicine Covance Biosimilars: Nonclinical & Clinical Development Challenges & Considerations

1. Biosimilars: Nonclinical and ClinicalDevelopment Challenges and Considerations 2. AgendaRegulatory EnvironmentEarly Development Challenges• Regulatory landscape• Characterization•…

Documents Pharma and Biotech Industry Outlook - A look at trends and opportunities in this increasingly...

1. Pharma and Biotech Industry Outlook A look at trends and opportunities in this increasingly challenging environment with a focus on the generics landscapeOctober [email protected]